MUMBAI, India, June 30 -- Intellectual Property India has published a patent application (202617048620 A) filed by Lepu Biopharma Co. , Ltd. on April 16, 2026, for Anti-Cdh17 Antibodies And Uses Thereof.
Inventors include Wu, Qi; Zeng, Peng; Yang, Yuanyuan; Cui, Feifei; Jiang, Wenqing; and Fang, Lei.
The application for the patent was published on June 26, 2026, under issue no. 26/2026.
Abstract: Antibodies having highly selective specificity to the human CDH17 protein are identified that are useful for treating cancer. The antibodies can be used to prepare antibody-drug conjugates, which exhibit efficient in vitro and in vivo tumor cell killings.
Disclaimer: Curated by HT Syndication.
